Effect of TPVB on Postoperative Pain and Cognitive Function After VATS in Elderly Patients
Postoperative Cognitive Dysfunction, Acute Postoperative Pain, Chronic Postsurgical Pain
About this trial
This is an interventional prevention trial for Postoperative Cognitive Dysfunction focused on measuring Thoracic paravertebral block, Cognitive function, Chronic Postsurgical Pain
Eligibility Criteria
Inclusion Criteria:
- BMI less than 30 kg/m2
- American Society of Anesthesiologists (ASA) grades I-III
- The score of Mini Mental state examination≥24
- The score of Montreal Cognitive Assessment-Beijing Scale≥26
Exclusion Criteria:
- Patients with heart, lung, brain and other vital organ disorders
- The score of Mini Mental state examination≤23
- The score of Montreal Cognitive Assessment-Beijing Scale≤25
- Preoperative psychiatric disorders or long-term use of drugs affecting the psychiatric system
- Have severe visual, hearing, speech impairment or other inability to communicate with the visitor
- Have contraindications to thoracic parathymic block
- Refuse to sign informed consent
Sites / Locations
- The First hosptial of Qinhuangdao
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Experimental
Other
Group C
Group T
Non-surgical controls
The general anesthesia was used.In this group, cognitive function was evaluated by MMSE and MoCA scale on one day before surgery, one day after surgery, and three months after surgery. Acute postoperative pain was was evaluated by VAS after extubation , one day after surgery, Chronic postsurgical pain was evaluated by VAS on three months after surgery.
Group T received 0.375% ropivacaine 20ml thoracic paravertebral nerve block combined with general anesthesia under ultrasound guidance after anesthesia induction.
Age and sex-matched community people are included for three sessions of MMSE test evaluation for calculation of POD incidence as normal control to in Z value calculation of POD incidence to rule out learning effect.